Assessing the clinical utility of biomarkers in medicine (Q40169397)

18 September 2017

title

Assessing the clinical utility of biomarkers in medicine (English)

1 reference

18 September 2017

0 references

Ramachandran S. Vasan

object named as

Ramachandran S Vasan

series ordinal

2

0 references

author name string

Nisha I Parikh

series ordinal

1

1 reference

18 September 2017

publication date

1 October 2007

1 reference

18 September 2017

published in

Biomarkers in Medicine

1 reference

18 September 2017

volume

1

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

419-436

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Biomarkers of cardiovascular disease: molecular basis and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Optimal diets for prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Novel Risk Markers and Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Understanding sensitivity and specificity with the right side of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundat

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

When can a risk factor be used as a worthwhile screening test?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Assessing the generalizability of prognostic information

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

A comparison of goodness-of-fit tests for the logistic regression model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

DNA microarrays: implications for cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

HUPO initiatives relevant to clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Modeling the heart--from genes to cells to the whole organ

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Computational analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Inflammatory markers and the risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of myeloperoxidase in patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Association between myeloperoxidase levels and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Soluble CD40L: risk prediction after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Cystatin C and the risk of death and cardiovascular events among elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The role of carotid arterial intima-media thickness in predicting clinical coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Carotid intima-media thickness as a measure of vascular target organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Endothelial function testing as a biomarker of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Arterial stiffness, wave reflections, and the risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic implications of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Troponins in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Limits of fine-mapping a quantitative trait

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

von Willebrand factor and coronary heart disease. Prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Left Ventricular Mass and Risk of Stroke in an Elderly Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Soluble CD40 Ligand in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.419

21 January 2018

Identifiers

DOI

10.2217/17520363.1.3.419

1 reference

18 September 2017

1 reference